The latest announcement is out from CervoMed (CRVO).
CervoMed Inc. is set to host an engaging virtual event on July 23, 2024, to discuss neflamapimod, a promising treatment for dementia with Lewy bodies. Investors and financial market enthusiasts can access important details about the company’s business performance, clinical studies, and future plans on the CervoMed website. This event is part of the company’s ongoing efforts to keep stakeholders informed and may be complemented by further updates as deemed necessary by the company’s management.
Learn more about CRVO stock on TipRanks’ Stock Analysis page.
